|
| |
| Cat. No |
Model |
Description |
Unit |
Price (VATº°µµ) |
³³±â |
Àç°í |
DataSheet |
ÁÖ¹®/°ßÀû |
| LCA-24-345247 |
AP02701PU-N |
14-3-3 protein zeta/delta//Human, Mouse/Rabbit |
1/EA |
|
|
|
 |
¹®ÀÇ |
|
|
|
|
|
|
|
Subject
|
14-3-3 protein zeta/delta |
|
Description
|
/ Human, Mouse/Rabbit |
|
Clonality
|
Mono |
|
Company
|
Acris Antibodies GmbH |
|
Application
|
Paraffin Sections, Western blot / Immunoblot |
|
Conjugation
|
|
|
Immunogen
|
|
|
Contents
|
Description: | Manufacturer | Acris Antibodies GmbH | | Quantity | 100 ug | | Reactivity | Human, Mouse | | Presentation | Aff - Purified | | Applications | Paraffin Sections, Western blot / Immunoblot | | Host | Rabbit | | PDF datasheet | view | | Shipping to | Worldwide | | Synonyms | YWHAZ, KCIP-1, FocusOn116 | | Swiss Prot Num | P63104 | | Immunogen | The antiserum was produced against synthesized non-phosphopeptide derived from human 14-3-3 zeta around the phosphorylation site of serine 58 (R-S-Sp-W-R). | | Product Type | Antibodies | | Storage | Store the antibody (in aliquots) at -20°C. Avoid repeated freezing and thawing. Shelf life: One year from despatch. | | References | 1. Gu YM, et al. (2006) FEBS Lett ; 580(1): 305-310. 2. Powell DW, et al. (2003) Mol Cell Biol; 23(15): 5376-5387. 3. Mackintosh C. (2004) Biochem J; 381(Pt 2): 329-342. | |
| Format | State: Liquid purified Ig fraction. | | ? | Purification: Immunoaffinity Chromatography. | | ? | Buffer System: PBS (without Mg2+ and Ca2+), pH 7.4, 150 mM NaCl, 0.02% Sodium Azide and 50% Glycerol. | |
| Specificity | The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen. 14-3-3 zeta (Ab-58) antibody detects endogenous levels of total 14-3-3 zeta protein. | | Application | Suitable for use in in Western blot (1:500-1:1000) and Immunohistochemistry (1:50-1:100). | | Concentration | 1.0 mg/ml | | Focuson | 116 Antibody Panel to Proteins of the 14-3-3 family (14-3-3 beta, 14-3-3 gamma, 14-3-3 epsilon, 14-3-3 zeta, 14-3-3 theta, 14-3-3 sigma, 14-3-3 eta) | |
|
|
|
|